Welcome to Boston! 👋 We're at @VascularSVS #VAM2026, Booth 311 today and tomorrow! Visit us to learn about the only FDA-cleared CT plaque analysis indicated for the carotid arteries and check out our software in action. 🕕 Today until 6 PM 🕑 Tomorrow until 2 PM See you there! #vascularsurgery #strokerisk #cardiovascularimaging #teamelucid

Pre-register today to reserve your spot: scct.org/events/register.asp… We're excited to help kick off #SCCT2026 with our hands-on dinner workshop happening on Thursday, July 9th, 2026 5:00-8:00 PM on site at SCCT in Chula Vista. We'll be exploring the evolution of CCTA—from traditional visual assessment to histology-based plaque analysis, plaque-derived FFRCT, and the emerging era of personalized lesion-level care. Through real-world cases, hands-on review, and expert-led discussion, attendees will gain practical insight into how advanced plaque characterization is helping shape the future of cardiovascular imaging and clinical decision-making. Elucid is proud and honored to support @Heart_SCCT for the Annual Scientific Meeting.

At #SCCT2026, Elucid will be sharing the science, technology, and vision helping drive the transition to the next generation of CCTA innovation. ❗Don't miss our Interactive Dinner Workshop on July 9, where attendees will explore live real-world cases and gain hands-on experience with our latest software. Register: scct.org/events/register.asp… Join us for a series of presentations and learning opportunities focused on plaque biology, physiology, clinical science, and the future of personalized cardiovascular care. #cardiology #yesCCT #preventivecardiology #precisionmedicine

We're excited to be supporting @VascularSVS Vascular Annual Meeting happening next week - right in our own beautiful city! 🍀 #VAM26 Stop by booth 311 to demo the first and only CT-based plaque analysis indicated for the carotid anatomy that can help physicians assess risk of rupture and ischemic #stroke 🧠 For those who are visiting Boston, we hope you get a chance to enjoy our city during the best season! Grab a Sam Adams 🍺, a lobster roll 🦞, and take a stroll in the Boston Public Garden 🌷 - you may just spot our office down the street! #strokeprevention

We had a great time at #SWFLCIS, as always! Great gathering to hear of the latest data and innovations in the #CCTA and preventive cardiology space, including a fantastic opening session by @BudoffMd, with highlights throughout the day focused on delivering optimal patient-specific care. #yesCCT Thanks for stopping by our demo and hanging out! Missed us? Stay tuned to hear about our many upcoming events! To schedule a 1:1 demo online, send us an email at info@elucid.com. Thank you Drs. Shone Almeida, @DrJamesThomps, @KashifAbbasSha1, @SWFLCIS

📰 Thank you @hcittoday for featuring Blake Richards in their latest article on how health IT solutions are improving the patient experience across access, communication, and continuity of care. Read more here: healthcareittoday.com/2026/0…

Thank you @OPCILive for an outstanding weekend of innovation, collaboration, and discussion around the future of cardiovascular care. We were honored to contribute to the conversation alongside some of the field’s leading interventional cardiologists and imaging experts. It’s exciting to see growing interest in how plaque biology, physiology, and advanced CCTA analysis can help inform more personalized treatment decisions. A very special thank you to Dr. Hiram Bezerra for representing Elucid and delivering an exceptional presentation ✨ Interested in learning more about the future of lesion-level cardiovascular care? Send us a DM or reach out at info@elucid.com. #OPCILive #interventionalcardiology #cardiology #CCTA #precisionmedicine

In just a few days, we'll be in Knoxville in support of @SWFLCIS! 🔬 Stop by and see our histology-validated CCTA analysis software in action. Schedule a demo ahead of time by sending us a DM. See you there! #SWFLCIS

We're proud to support @OPCILive this year in New York! From plaque biology to personalized decision-making, Elucid is helping redefine how cardiovascular disease is understood through advanced CCTA analysis. Join us to explore histology-based plaque characterization, lesion-level insight, and the future of precision cardiovascular imaging.

Just dropped 🎤 Tune in to the latest episode of Donut of Destiny, featuring @amir_ahmadi__: donutofdestiny.buzzsprout.co… This conversation highlights the concept of the field's transitional journey from CT 1.0 to CT 2.0 to CT 3.0 and the importance of validation and reproducibility. The key is moving from identifying anatomy to understanding biology, and finally to enabling truly personalized cardiovascular care. Dr. Ahmadi, together with host @PraveenRangana9, explore a roadmap featuring the evolution of AI-enabled CCTA into a comprehensive decision-support platform for prevention, intervention, and longitudinal disease management. Listen to learn more! Thank you @Heart_SCCT and Dr. Ranganath for yet another fantastic discussion🫀 #yesCCT #cardiotwitter #preventivecardiology

Hot off the press ♨️ Blake Richards, COO, deep dives into how #AIinHealthcare is moving beyond hype, and into the realities of clinical practice. Explore how advanced CCTA and AI-driven plaque analysis are helping shift cardiovascular care toward earlier detection and more personalized decision-making 🩺 As AI adoption accelerates, the future belongs to technologies that are not just innovative, but clinically actionable, explainable, and built for real-world care. Read more in @MedEconomics: medicaleconomics.com/view/ma… TL;DR: What it actually takes for AI diagnostics to succeed in the real world: strong evidence, reimbursement, workflow integration, and physician trust. Thank you @tshryock! #cardiology #CCTA #yesCCT #preventivecardiology #precisionmedicine

We’re honored to share that Plaque-IQ™ has been named “Best New Cardiology Technology Solution” in the 10th annual @MedTech_Awards 🎉 By providing insight into plaque biology, including high-risk features like lipid rich necrotic core, Plaque-IQ helps physicians make more informed, patient-specific decisions to prevent heart attack and stroke 🫀🧠 As CVD remains the leading cause of death worldwide, we’re proud to be part of the shift toward earlier detection and more personalized care. Want to learn more? Reach out to demo our technology and join us on our mission! Read the news here: elucid.com/elucid-medtechbre… #HistologyMatters #MedTech #Cardiology #CCTA #PrecisionMedicine #HealthcareInnovation

It’s always inspiring to spend time with teams who are pushing cardiovascular care forward. Thank you @MidwestCardio for your partnership and for your commitment to bringing more precise, patient-specific insights into everyday care! #cardiology #cardiovascularcare #yescct #precisionmedicine

Our office will be closed on Monday, April 20th, for Patriot's Day - and for the 130th #BostonMarathon! This one is very special for us, as our very own Sonal Ambwani will be racing this year! Many of us will be watching from around the city, cheering her on. Good luck, Sonal 🫶 - see you at the finish line! 👟🦄 #TeamElucid

Dr. Robert Pelberg, SVP of Medical Affairs, shares his outlook on the critical shift in how we understand and assess cardiovascular disease with @DAICeditor. Read here: dicardiology.com/article/bey… Three key takeaways: 🫀 A large percentage of heart attacks don’t come from severe blockages. Many events originate from plaques that were previously non–flow limiting (<50% stenosis), exposing the limits of a stenosis-only approach. 🔬 Plaque biology drives risk. Features like lipid-rich necrotic core and plaque structure are key determinants of vulnerability, even when arteries appear only mildly narrowed. 🔎 Advanced imaging is enabling a new paradigm. #CCTA and emerging technologies like Elucid's Plaque-IQ are expanding the ability to assess plaque burden and composition, offering a more complete view of disease. #Cardiology #CoronaryPlaque #PreventiveCardiology #CardiovascularImaging #PrecisionMedicine

🚨 News just announced! 🚨 We're excited to introduce the commercial availability of our Lesion Inspection Tool for Plaque-IQ™, bringing lesion-level plaque analysis directly to physicians. Read more: elucid.com/elucid-lesion-ins… 🔎 This new capability enables clinicians to interrogate individual lesions, quantify plaque composition, including high-risk features like lipid-rich necrotic core (LRNC), and gain deeper insight into a patient’s true disease burden. Plaque-IQ continues to advance more precise, personalized cardiovascular care, helping physicians better assess risk and guide treatment decisions. 🫀🧠 #Cardiology #CCTA #yesCCT #PlaqueAnalysis #PrecisionMedicine #CardiovascularImaging

Today is the @WHO's #WorldHealthDay, a moment to celebrate health advances rooted in science. At Elucid, this belief is at the core of everything we do. Our technology is built on #histology, the gold standard for understanding disease at the tissue level. By translating histological insight into CT-based plaque analysis, we’re helping physicians better understand plaque, assess individual risk, and make more informed, patient-specific treatment decisions. #CardiovascularHealth #PrecisionMedicine #MedicalInnovation #HistologyMatters #yesCCT

Today is the @WHO's #WorldHealthDay, a moment to celebrate health advances rooted in science. At Elucid, this belief is at the core of everything we do. Our technology is built on #histology, the gold standard for understanding disease at the tissue level. By translating histological insight into CT-based plaque analysis, we’re helping physicians better understand plaque, assess individual risk, and make more informed, patient-specific treatment decisions. #CardiovascularHealth #PrecisionMedicine #MedicalInnovation #HistologyMatters #yesCCT